Study of FID-022 in Participants With Advanced Solid Tumors

Clinical trial NCT06694480 · RECRUITING

Trial details

NCT number: NCT06694480
Sponsor: Fulgent Pharma LLC.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2025-07-03
Primary completion: 2027-12-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.